Filter by: patients
Home > Community Treatment Reports and Side Effects > Rosiglitazone Treatment Report
What is Rosiglitazone?

Rosiglitazone is an antidiabetic agent used for type 2 diabetes to improve glycemic control as an adjunct to diet and exercise. It may be used in combination when diet, exercise and a single agent do not result in adequate control. Off label it is used for polycystic ovary syndrome.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Diabetes Type 2 6 3 Efficacy_major Efficacy_moderate
Other 4 0
Pre diabetes 1 0
Lipodystrophy (lipoatrophy or loss of fatty tissue) 1 0

See all 7 patients currently taking Rosiglitazone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 0
None
 2

Commonly reported side effects, conditions, and hospitalizations associated with Rosiglitazone

Weight gain 1

Reported Dosages

  daily 1 other daily 2 mg daily 4 mg daily 8 daily 8 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Rosiglitazone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2   Doctor's advice: 40%
Course of treatment ended 2   Course of treatment ended: 40%
Did not seem to work 1   Did not seem to work: 20%
Personal research 1   Personal research: 20%
Other 1   Other: 20%
Not indicated 1   Not indicated: 20%

See all 5 patients who’ve stopped taking Rosiglitazone

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Rosiglitazone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Rosiglitazone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Rosiglitazone

Always
 3 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Rosiglitazone

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 3 100%

Cost

Paid out of pocket

Cost of Rosiglitazone

$200+
 0 0%
$100-199
 1 50%
$50-99
 1 50%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.